Literature DB >> 18333210

Indications for non-transplant surgery in primary sclerosing cholangitis.

Bastian Domajnko1, Steven A Ahrendt.   

Abstract

Primary sclerosing cholangitis (PCS) is a progressive disease leading to secondary biliary cirrhosis. Patients are at increased risk of developing cholangiocarcinoma, which is usually diagnosed at an advanced stage. Treatment of PCS includes medical therapy, endoscopic biliary dilation, percutaneous transhepatic stenting, extrahepatic biliary resection and liver transplantation. The most effective management of primary sclerosing cholangitis before the onset of cirrhosis remains unclear. Non-transplant surgical procedures have a limited but defined role in patients with PCS. Resection of the extrahepatic biliary tree in symptomatic non-cirrhotic patients improves hyperbilirubinaemia and prolongs both transplant-free and overall survival when compared with non-operative dilation and/or stenting. Surgical resection may also definitively establish or exclude a diagnosis of cholangiocarcinoma in patients with dominant extrahepatic or perihilar strictures. Extrahepatic bile duct resection may also reduce the risk of cholangiocarcinoma. Extrahepatic biliary resection should be considered in selected non-cirrhotic patients with symptomatic biliary obstruction and dominant extrahepatic and/or perihilar strictures. Those patients in whom cholangiocarcinoma is suspected should also undergo resection.

Entities:  

Year:  2005        PMID: 18333210      PMCID: PMC2043109          DOI: 10.1080/13651820500273392

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  35 in total

1.  Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis.

Authors:  M Kaya; B T Petersen; P Angulo; T H Baron; J C Andrews; C J Gostout; K D Lindor
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

2.  Ursodeoxycholic acid does not improve the clinical course of primary sclerosing cholangitis over a 2-year period.

Authors:  N De Maria; A Colantoni; E Rosenbloom; D H Van Thiel
Journal:  Hepatogastroenterology       Date:  1996 Nov-Dec

3.  Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment.

Authors:  Adolf Stiehl; Gerda Rudolph; Petra Klöters-Plachky; Peter Sauer; Siegfried Walker
Journal:  J Hepatol       Date:  2002-02       Impact factor: 25.083

4.  A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis.

Authors:  T A Knox; M M Kaplan
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

5.  Differential diagnosis of stenosing lesions at the hepatic hilus.

Authors:  Jonathan Koea; Andrew Holden; Kai Chau; John McCall
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

6.  Cholangiocarcinoma complicating primary sclerosing cholangitis.

Authors:  C B Rosen; D M Nagorney; R H Wiesner; R J Coffey; N F LaRusso
Journal:  Ann Surg       Date:  1991-01       Impact factor: 12.969

7.  Surgical biliary drainage in primary sclerosing cholangitis. The role of the Hepp-Couinaud approach.

Authors:  J A Myburgh
Journal:  Arch Surg       Date:  1994-10

8.  Primary sclerosing cholangitis: liver transplantation or biliary surgery.

Authors:  O Farges; B Malassagne; M Sebagh; H Bismuth
Journal:  Surgery       Date:  1995-02       Impact factor: 3.982

9.  Unusual causes of benign biliary strictures with cholangiographic features of cholangiocarcinoma.

Authors:  Charles E Binkley; Frederick E Eckhauser; Lisa M Colletti
Journal:  J Gastrointest Surg       Date:  2002 Sep-Oct       Impact factor: 3.452

Review 10.  Endoscopic management of primary sclerosing cholangitis: review, and report of an open series.

Authors:  A A Gaing; J M Geders; S A Cohen; J H Siegel
Journal:  Am J Gastroenterol       Date:  1993-12       Impact factor: 10.864

View more
  1 in total

Review 1.  Primary sclerosing cholangitis.

Authors:  Marina G Silveira; Keith D Lindor
Journal:  Can J Gastroenterol       Date:  2008-08       Impact factor: 3.522

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.